Be the first to know about every new Coronavirus story

Germany, France, Italy and Spain will resume using the Oxford/AstraZeneca coronavirus vaccine

Europe’s biggest countries are set to resume using the Oxford/AstraZeneca coronavirus vaccine after the EU drugs regulator said the jab was safe, and the US is taking a tough stance as members from the Biden administration meet with Chinese officials in Alaska. Plus, the FT’s markets editor, Katie Martin, explains why investors are reboarding airline stocks. 


EU drugs regulator backs ‘safe and effective’ AstraZeneca vaccine

https://www-ft-com.ezp-prod1.hul.harvard.edu/content/c83944d5-ad26-415f-bf34-1eba428beeb9


US signals tough stance ahead of first meeting with China

https://www-ft-com.ezp-prod1.hul.harvard.edu/content/b8af8a5b-591d-4721-8a6c-4da5481f3348?


Airlines tap stock and bond markets as they prepare for surge in bookings

https://www-ft-com.ezp-prod1.hul.harvard.edu/content/2a4d69a9-3f3d-4e0e-8e82-6794bca1888a



See acast.com/privacy for privacy and opt-out information.

A transcript for this podcast is currently unavailable, view our accessibility guide.

Get alerts on FT News Briefing when a new story is published

Copyright The Financial Times Limited 2021. All rights reserved.
Reuse this content (opens in new window)

Comments have not been enabled for this podcast.

Follow the topics in this podcast